Fakultni poliklinika VFN

Prague 128 08

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Breast Cancer, Polycystic Kidney, Autosomal Dominant, Primary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer — Running, not enrolling
• A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis — Completed
• Bosutinib For Autosomal Dominant Polycystic Kidney Disease — Completed